WPD Pharmaceuticals, Inc. is a biotechnology research and development company, which engages in the research and development of medicinal products involving biological compounds and small molecules. Its products include WPD101, Berubicin, WP1066, WP1732, WPD102, WPD103, WP1220, and Annamycin. The company was founded on July 4, 2006 and is headquartered in Vancouver, Canada.